Theme: Joining Hands in the Fight against Melanoma and Carcinoma Cancer

Melanoma 2016

Renowned Speakers

Melanoma 2016

ConferenceSeries Ltd offers all the participants across the globe to join ‘Global Summit on Melanoma & Carcinoma’ in July 14-15, 2016 at Brisbane, Australia.

Melanoma 2016 leads towards main problems and future strategies of cancer which is going to be the leading and most promising international conference. The program delivers an opportunity for participants related to Oncologists, Dermatologists, Radiologists, Skin cancer Specialists & all the entire medical team from skin cancer departments. The conference will be structured around the theme “Joining Hands in the Fight against Melanoma and Carcinoma Cancer”.

ConferenceSeries Ltd, the host of this conference is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe.

With participants around the world focused on learning about Melanoma and Carcinoma treatment this is your best opportunity to reach the major assemblage of participants from the Melanoma communityoncology society, and American oncology society. Conduct presentations, distribute the information, meet with recent and potential Cancer scientists, make a splash with new drug developments, and obtain name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the latest updates in Melanoma and Carcinoma are hallmarks of this Global Skin cancer conference.

Melanoma 2016 mainly focus on the Melanoma, Carcinoma, Malignant melanoma, Causes, Staging, Diagnosis, Laboratory Diagnostic Tests, ways for the Treatment, various Therapies, Biomarkers of skin cancer,  future advance research, Cancer Nanotechnology, and its case reports.

Track 1: Melanoma

Superficial spreading melanoma in which the malignant cells tend to stay within the tissue of origin, the epidermis. Lentigo maligna also known as sun-damaged skin that consists of malignant cells but does not show invasive growth. Acral lentiginous melanoma is characterised by its origin: palm, sole, or beneath the nail. It is more common on feet than on hands. Nodular melanoma is the most aggressive type of melanoma. It grows more rapidly in thickness than in diameter. Amelanotic melanoma is a skin cancer in which the cell does not make melanin. They can be pink, red, purple or normal skin colour. Melanoma develops if there is uncontrolled growth of melanocytes; these cells are responsible for pigmentation. The majority of melanomas are cutaneous which grows within the skin. Melanoma is a type of skin cancer which spreads to other places in your body.

Related Melanoma ConferenceCarcinoma ConferencesSkin Cancer ConferenceCancer Conferences

Melanoma Conference, July 14-15, 2016 Brisbane, Australia; 10th Global Annual Oncologists Meeting, July 11-13, 2016 Cologne, Germany;  Cervical Cancer Conference, August 04-05, 2016 Manchester, UK; Oral Cancer Conference, August 15-17, 2016 Portland, Oregon, USA; 2nd Prostate Cancer Conference, August 22-23, 2016 Philadelphia, USA, Throat Cancer Conference August 15-17, 2016 Portland, Oregon, USA, Carcinoma Conference, July 14-15, 2016 Brisbane, Australia, Mouth Cancer Conference August 15-17, 2016 Portland, Oregon, USA; 2016 Society for Melanoma Research Congress November 6–9, 2016 Boston, Massachusetts; 16th World Congress on Cancers of the Skin August 31 – September 3, 2016 Vienna, Austria ; 12th Congress of the European Association of Dermato-Oncology August 31- Sep 3, 2016 Vienna, Austria; 4th Life and Cancer Conference 20-21 April 2017, EU Parliament, Brussels, Belgium; 13th Gastric Cancer Congress 08-11 May 2019,Prague, Czech Republic; Molecular Targets and Cancer Therapeutics conference 15-19 November 2019,Miami, Florida, USA; 12th Melanoma and Other Cutaneous Malignancies February 20, 2016 Miami Beach;  Melanoma Conference 28 – 29 October 2016, Sofitel, Sydney.

Track 2Carcinoma

Basal cell carcinoma is common form of all cancers. It occurs in cells lining the deepest part of the skin's outer layer. Squamous cell carcinoma develops on the skin. Sometimes, it may spread to the lymph nodes. Adenocarcinoma is neoplastic of epithelial tissue and it has glandular origin, glandular characteristics or both. Anaplastic carcinoma arises from uncontrolled proliferation of transformed cells from epithelial origin. Adenosquamous carcinoma is a type of cancer that contains two types of cells one is squamous cells organs and other is gland-like cells. Bronchogenic carcinoma is neoplasm of the lung which arises from the epithelium of the bronchus or bronchiole. Oat-cell carcinoma is highly malignant cancer that arises within the lung. Lung Carcinoma also known as pulmonary carcinoma which is a malignant lung tumor which has uncontrolled cell growth in tissues of the lung.

Related Melanoma ConferenceCarcinoma ConferencesSkin Cancer ConferenceCancer Conferences

Leukemia Conference, October 17-18, 2016, Italy; 12th World Cancer Conference, September 26-28, 2016 London, UK;  Surgical Oncology Conference, October 03-05, 2016 Atlanta, Georgia, USA 13th Asia-Pacific Oncologists Annual Meeting, October 17-19, 2016, Malaysia, 14th World Cancer Convention, November 21-23, 2016 Dubai, UAE, Bone Marrow Transplantation Conference, October 17-18, 2016,Italy; 25th EADV Congress 28 September - 2 October 2016 - Vienna, Austria; Focus on Melanoma Meeting, RCP, 21 October 2016; 13th International Congress of the Society for Melanoma Research, November 6–9 2016, Boston, Massachusetts; Innovation and Biomarkers in Cancer Drug Development (IBCD) 8-9 September, Brussels, Belgium; Gynecological Cancer Group fall meeting 23-24 September, Lausanne, Switzerland; Gastrointestinal Tract Cancer Group autumn meeting20-22 October, Warsaw, Poland; Melanoma Group meeting, 27-28 October, Lisbon, Portugal; EORTC Symposium on Multidisciplinary Quality Assurance at World Cancer Congress 2016 01 November, Paris, France;

Track 3Malignant Melanoma

Melanoma is also known as malignant melanoma which is a type of cancer that develops from the pigment-containing cells known as melanocytes. These are the cells which produces melanin which gives colour to our skin. It is a less common, but most dangerous form of skin cancer and that may originate in any part of the body which contains the skin pigment producing cells. Mostly skin cancers are caused by too much exposure to the sun’s ultraviolet rays. Nodular melanoma is aggressive form of melanoma and it grows more rapidly in thickness than in diameter which penetrates into the skin. Oral melanomas are uncommon, and, similar to their cutaneous counterparts, they may arise primarily from melanocytes in the basal layer of the squamous mucosa. Invasive melanomas are more serious, as they penetrate deeper into the skin and may have spread to other areas of the body.

Related Melanoma ConferenceCarcinoma ConferencesSkin Cancer ConferenceCancer Conferences

10th Global Annual Oncologists Meeting, July 11-13, 2016 Cologne, Germany; Melanoma Conference, July 14-15, 2016 Brisbane, Australia; Cervical Cancer Conference, August 04-05, 2016 Manchester, UK; Oral Cancer Conference, August 15-17, 2016 Portland, Oregon, USA; 2nd Prostate Cancer Conference, August 22-23, 2016 Philadelphia, USA, Throat Cancer Conference August 15-17, 2016 Portland, Oregon, USA, Carcinoma Conference, July 14-15, 2016 Brisbane, Australia, Mouth Cancer Conference August 15-17, 2016 Portland, Oregon, USA, 16th World Congress on Cancers of the Skin 31st Aug 03 Sep 2016 Vienna, Austria; Clinical Trials – In vitro Diagnostics – Data Protection 07th September Brussels, Belgium; Innovation and Biomarkers in Cancer Drug Development (IBCD) 8-9 September, Brussels, Belgium; Gynaecological Cancer Group fall meeting 23-24 September, Lausanne, Switzerland; Gastrointestinal Tract Cancer Group autumn meeting 20-22 October, Warsaw, Poland; Melanoma Group meeting, 27-28 October, Lisbon, Portugal; EORTC Symposium on Multidisciplinary Quality Assurance at World Cancer Congress 2016 01 November, Paris, France; Radiation Oncology Group meeting, 07-08 November, Berlin, Germany;

Track 4: Melanoma and Carcinoma: Cause

Melanoma is a type of cancer which develops from the pigment containing cells called melanocytes. These are the cells that produce melanin which is a pigment that gives colours to our skin. It is a less common, but most dangerous form of skin cancer. Ultraviolet rays are most common reason for skin cancers which were caused by too much exposure to the sun’s ultraviolet rays. The two types of UV rays that cause melanoma are UV-A and UV-B rays. A number of reasons often run in families, greatly increase melanoma susceptibility. Several genes increase risk of melanoma. The persons born with the giant congenital melanocytic nevi are at risk. Possible significant elements in determining risk may include the intensity and duration of sun exposure, the age at which sun exposure occurs to the person. UV radiation will cause damage to the DNA of cells.

Related Melanoma ConferenceCarcinoma ConferencesSkin Cancer ConferenceCancer Conferences

10th Global Annual Oncologists Meeting, July 11-13, 2016 Cologne, Germany; Melanoma Conference, July 14-15, 2016 Brisbane, Australia; Cervical Cancer Conference, August 04-05, 2016 Manchester, UK; Oral Cancer Conference, August 15-17, 2016 Portland, Oregon, USA; 2nd Prostate Cancer Conference, August 22-23, 2016 Philadelphia, USA, Throat Cancer Conference August 15-17, 2016 Portland, Oregon, USA, Carcinoma Conference, July 14-15, 2016 Brisbane, Australia, Mouth Cancer Conference August 15-17, 2016 Portland, Oregon, USA, 16th World Congress on Cancers of the Skin 31st Aug 03 Sep 2016 Vienna, Austria; Clinical Trials – In vitro Diagnostics – Data Protection 07th September Brussels, Belgium; Innovation and Biomarkers in Cancer Drug Development (IBCD) 8-9 September, Brussels, Belgium; Gynecological Cancer Group fall meeting 23-24 September, Lausanne, Switzerland; Gastrointestinal Tract Cancer Group autumn meeting 20-22 October, Warsaw, Poland; Melanoma Group meeting, 27-28 October, Lisbon, Portugal; EORTC Symposium on Multidisciplinary Quality Assurance at World Cancer Congress 2016 01 November, Paris, France; Radiation Oncology Group meeting, 07-08 November, Berlin, Germany;

Track 5: Melanoma Staging

The stages refers to the thickness, depth of penetration, and the degree of which melanoma has been spreaded. The staging is used to determine treatment for Melanoma. The melanoma stages can be distinguished as early melanomas (Stages 0 and I) are localized; Stage 0 tumors may be in situ also, that means they are non-invasive and not penetrated below the surface of the skin. While Stage I tumors are invaded in the skin but are small and nonulcerated, and grows at slow mitotic rate. Stage II tumors, though localized but they are larger (generally over 1 mm. thick) and may be ulcerated or have a mitotic rate which is greater than 1/mm2; they are considered as intermediate melanomas. More advanced melanomas (Stages III and IV) spread to other parts of the body. These are also subdivisions within stages.

Related Melanoma ConferenceCarcinoma ConferencesSkin Cancer ConferenceCancer Conferences

Carcinoma Conference, July 14-15, 2016 Brisbane, Australia; 2nd  Paediatric Oncology Conference , June 22-23, 2017 Philadelphia, USA; 2nd  Prostate Cancer Conference, August 22-23, 2016 Philadelphia, Pennsylvania, USA; 10th Global Annual Oncologists Meeting, July 11-13, 2016 Cologne, Germany; Melanoma Conference, July 14-15, 2016 Brisbane, Australia;12th World Cancer ConferenceSeptember 26-28, 2016 London, UK , 12th Congress of the European Association of Dermato-Oncology August 31- Sep 3, 2016 Vienna, Austria;  25th EADV Congress 28 September - 2 October 2016 - Vienna, Austria; Focus on Melanoma Meeting, RCP, 21 October 2016; 13th International Congress of the Society for Melanoma Research, November 6–9 2016, Boston, Massachusetts; Radiation Oncology Group meeting, 07-08 November, Berlin, Germany;  4th Life and Cancer Conference 20-21 April 2017, EU Parliament, Brussels, Belgium; 13th International Gastric Cancer Congress 08-11 May 2019,Prague, Czech Republic;  Molecular Targets and Cancer Therapeutics conference 15-19 November 2019,Miami, Florida, USA; 12th International Symposium on Melanoma and Other Cutaneous Malignancies February 20, 2016 Miami Beach;

Track 6: Melanoma and Carcinoma Diagnosis

A symmetrical skin lesion to which the border of the lesion is irregular. Melanomas usually have multiple colours. Diameters of moles greater than 6 mm are more likely to be melanomas than smaller moles. A Seborrheic keratosis is a benign skin growth that originates in keratinocytes. An ugly duckling may be a single large mole which is dark in amongst a sea of smaller lighter moles, or it may be a single small light mole in amongst a sea of large dark moles. Skin biopsy is a biopsy technique in which a skin lesion is removed. Intraocular melanoma is a disease in which malignant cells forms in the tissues of the eye. The tumor microenvironment is having cellular environment in which the tumor exists, including the surrounding blood vessels, immune cells and fibroblasts. The immune cells in the microenvironment can affect the growth and evolution of cancerous cells. The environmental factors may produce more risk of carcinoma cancer.

Related Melanoma ConferenceCarcinoma ConferencesSkin Cancer ConferenceCancer Conferences

Melanoma Conference, July 14-15, 2016 Brisbane, Australia; 10th Global Annual Oncologists Meeting, July 11-13, 2016 Cologne, Germany;  Cervical Cancer Conference, August 04-05, 2016 Manchester, UK; Oral Cancer Conference, August 15-17, 2016 Portland, Oregon, USA; 2nd Prostate Cancer Conference, August 22-23, 2016 Philadelphia, USA, Throat Cancer Conference August 15-17, 2016 Portland, Oregon, USA, Carcinoma Conference, July 14-15, 2016 Brisbane, Australia, Mouth Cancer Conference August 15-17, 2016 Portland, Oregon, USA; 2016 Society for Melanoma Research Congress November 6–9, 2016 Boston, Massachusetts; 16th World Congress on Cancers of the Skin August 31 – September 3, 2016 Vienna, Austria ; 12th Congress of the European Association of Dermato-Oncology August 31- Sep 3, 2016 Vienna, Austria; 4th Life and Cancer Conference 20-21 April 2017, EU Parliament, Brussels, Belgium; 13th Gastric Cancer Congress 08-11 May 2019,Prague, Czech Republic; Molecular Targets and Cancer Therapeutics conference 15-19 November 2019,Miami, Florida, USA; 12th Melanoma and Other Cutaneous Malignancies February 20, 2016 Miami Beach;  Melanoma Conference 28 – 29 October 2016, Sofitel, Sydney.

Track 7: Melanoma and Carcinoma: Treatment

Surgery to remove margin of normal skin around the melanoma occurred. The amount of normal skin removed depends on the thickness and location of the melanoma occurred but not more than 2 cm (4/5 inch) and the normal skin needs to be removed from all sides of the melanoma. The wider margins make more healing and have not been found to help people live longer. If cancer cells found on the sentinel lymph node then the dissection process is recommended, but it’s not clear whether  it helpful to improve survival. Skin tumors or enlarged lymph nodes causing symptoms can be removed by surgery or they may be treated with radiation therapy. Metastases in internal organs are sometimes removed, depending on how many are there, where they are found, and how likely they are to causing symptoms. Metastases cannot be removed they are treated with radiation, immunotherapy, targeted therapy, or chemotherapy.

Related Melanoma ConferenceCarcinoma ConferencesSkin Cancer ConferenceCancer Conferences

Melanoma Conference, July 14-15, 2016 Brisbane, Australia; 10th Global Annual Oncologists Meeting, July 11-13, 2016 Cologne, Germany;  Cervical Cancer Conference, August 04-05, 2016 Manchester, UK; Oral Cancer Conference, August 15-17, 2016 Portland, Oregon, USA; 2nd Prostate Cancer Conference, August 22-23, 2016 Philadelphia, USA, Throat Cancer Conference August 15-17, 2016 Portland, Oregon, USA, Carcinoma Conference, July 14-15, 2016 Brisbane, Australia, Mouth Cancer Conference August 15-17, 2016 Portland, Oregon, USA; 2016 Society for Melanoma Research Congress November 6–9, 2016 Boston, Massachusetts; 16th World Congress on Cancers of the Skin August 31 – September 3, 2016 Vienna, Austria ; 12th Congress of the European Association of Dermato-Oncology August 31- Sep 3, 2016 Vienna, Austria; 4th Life and Cancer Conference 20-21 April 2017, EU Parliament, Brussels, Belgium; 13th Gastric Cancer Congress 08-11 May 2019,Prague, Czech Republic; Molecular Targets and Cancer Therapeutics conference 15-19 November 2019,Miami, Florida, USA; 12th Melanoma and Other Cutaneous Malignancies February 20, 2016 Miami Beach;  Melanoma Conference 28 – 29 October 2016, Sofitel, Sydney.

Track 8: Melanoma and Carcinoma: Therapy

Therapy for melanoma after initial treatment depends on the stage of the melanoma, what treatments that person already had, where that melanoma comes again, and other factors are considered. Melanoma and carcinoma might come again on the skin or near the site of the original tumor, sometimes even in the scar from the surgery it depends. In general case, these local recurrences are treated with surgery for a primary melanoma. Depending on the thickness and location of the melanoma tumor, therapies and other treatments may be considered, such as isolated limb perfusion chemotherapy; radiation therapy; Biological therapy; Cow’s Urine Therapy; tumor injection with BCG vaccine, interferon, or interleukin-2. There are even systemic treatments such as Retroviral mediated gene therapy; Oncolytic virotherapy; immunotherapy, chemotherapy or targeted therapy.

Related Melanoma ConferenceCarcinoma ConferencesSkin Cancer ConferenceCancer Conferences

10th Global Annual Oncologists Meeting, July 11-13, 2016 Cologne, Germany; Melanoma Conference, July 14-15, 2016 Brisbane, Australia; Cervical Cancer Conference, August 04-05, 2016 Manchester, UK; Oral Cancer Conference, August 15-17, 2016 Portland, Oregon, USA; 2nd Prostate Cancer Conference, August 22-23, 2016 Philadelphia, USA, Throat Cancer Conference August 15-17, 2016 Portland, Oregon, USA, Carcinoma Conference, July 14-15, 2016 Brisbane, Australia, Mouth Cancer Conference August 15-17, 2016 Portland, Oregon, USA, 16th World Congress on Cancers of the Skin 31st Aug 03 Sep 2016 Vienna, Austria; Clinical Trials – In vitro Diagnostics – Data Protection 07th September Brussels, Belgium; Innovation and Biomarkers in Cancer Drug Development (IBCD) 8-9 September, Brussels, Belgium; Gynecological Cancer Group fall meeting 23-24 September, Lausanne, Switzerland; Gastrointestinal Tract Cancer Group autumn meeting 20-22 October, Warsaw, Poland; Melanoma Group meeting, 27-28 October, Lisbon, Portugal; EORTC Symposium on Multidisciplinary Quality Assurance at World Cancer Congress 2016 01 November, Paris, France; Radiation Oncology Group meeting, 07-08 November, Berlin, Germany;

Track 9: Melanoma and Carcinoma: Biomarkers

A cancer biomarker refers to a substance that indicates the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor. The Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used mostly for the cancer diagnosis, prognosis, and epidemiology. Ideally, such biomarkers can be assayed in non-invasively collected from bio fluids like blood or serum. The ambiguous melanocytic neoplasms which are benign nevi from those that represent true melanoma for treatment and prognosis. Diagnostic biomarkers currently used to assist in the diagnosis of melanoma are usually it is only for melanocytic malignant neoplasm and not for their ability to metastasize. Traditional prognostic biomarkers include invasion and mitotic count. Newer diagnostic and prognostic biomarker utilizes immunohistochemical staining with ribonucleic acid, micro-ribonucleic acid, and deoxyribonucleic acid assays and fluorescence in situ hybridization. Improved diagnostic and prognostic biomarkers are increasing importance in the treatment of melanoma with the development of newer and more targeted therapies.

Related Melanoma ConferenceCarcinoma ConferencesSkin Cancer ConferenceCancer Conferences

Carcinoma Conference, July 14-15, 2016 Brisbane, Australia; 2nd  Paediatric Oncology Conference , June 22-23, 2017 Philadelphia, USA; 2nd  Prostate Cancer Conference, August 22-23, 2016 Philadelphia, Pennsylvania, USA; 10th Global Annual Oncologists Meeting, July 11-13, 2016 Cologne, Germany; Melanoma Conference, July 14-15, 2016 Brisbane, Australia;12th World Cancer ConferenceSeptember 26-28, 2016 London, UK , 12th Congress of the European Association of Dermato-Oncology August 31- Sep 3, 2016 Vienna, Austria;  25th EADV Congress 28 September - 2 October 2016 - Vienna, Austria; Focus on Melanoma Meeting, RCP, 21 October 2016; 13th International Congress of the Society for Melanoma Research, November 6–9 2016, Boston, Massachusetts; Radiation Oncology Group meeting, 07-08 November, Berlin, Germany;  4th Life and Cancer Conference 20-21 April 2017, EU Parliament, Brussels, Belgium; 13th International Gastric Cancer Congress 08-11 May 2019,Prague, Czech Republic;  Molecular Targets and Cancer Therapeutics conference 15-19 November 2019,Miami, Florida, USA; 12th International Symposium on Melanoma and Other Cutaneous Malignancies February 20, 2016 Miami Beach;

Track 10: Melanoma and Carcinoma: Advance research

Advances in Cancer Research have covered a remarkable period of discovery that encompasses the beginning of the revolution in biology. Melanoma is common type of skin cancer, but the most deadly cancer. It accounts approximately four per cent of all skin cancer cases, but 80% of skin cancer deaths. Melanoma can be challenging to diagnose and tests uses a gene to differentiate malignant melanoma from benign skin lesions. Chemoprevention refers to the use of agents to prevent carcinogenic progression of cancer. Chemoprevention is an unexplored strategy in melanoma preventionDNA vaccination with advanced malignant melanoma is an safe and potentially therapeutic. Even Though early detection, appropriate surgery, and in some cases adjuvant therapy improved outcomes for at least one third of patients with early-stage melanoma which will develop metastases. The effort to potentially maximize outcomes biochemotherapy was evaluated.

Related Melanoma ConferenceCarcinoma ConferencesSkin Cancer ConferenceCancer Conferences

Melanoma Conference, July 14-15, 2016 Brisbane, Australia; 10th Global Annual Oncologists Meeting, July 11-13, 2016 Cologne, Germany;  Cervical Cancer Conference, August 04-05, 2016 Manchester, UK; Oral Cancer Conference, August 15-17, 2016 Portland, Oregon, USA; 2nd Prostate Cancer Conference, August 22-23, 2016 Philadelphia, USA, Throat Cancer Conference August 15-17, 2016 Portland, Oregon, USA, Carcinoma Conference, July 14-15, 2016 Brisbane, Australia, Mouth Cancer Conference August 15-17, 2016 Portland, Oregon, USA; 2016 Society for Melanoma Research Congress November 6–9, 2016 Boston, Massachusetts; 16th World Congress on Cancers of the Skin August 31 – September 3, 2016 Vienna, Austria ; 12th Congress of the European Association of Dermato-Oncology August 31- Sep 3, 2016 Vienna, Austria; 4th Life and Cancer Conference 20-21 April 2017, EU Parliament, Brussels, Belgium; 13th Gastric Cancer Congress 08-11 May 2019,Prague, Czech Republic; Molecular Targets and Cancer Therapeutics conference 15-19 November 2019,Miami, Florida, USA; 12th Melanoma and Other Cutaneous Malignancies February 20, 2016 Miami Beach;  Melanoma Conference 28 – 29 October 2016, Sofitel, Sydney.

Track 11Oncologists

Oncology practices provides oncologists, dermatologistsradiologists, clinical oncologists and other oncology   professionals with  lot of information to enhance practice efficiency and promote a high standard  quality for the patient care. For the thyroid cancer, oesophageal oncology, uterine oncology, paediatric oncology research is basically focussed on incidence and epidemiology, diagnosis, staging, risk assessment and management of differentiated cancer.

Related Melanoma ConferenceCarcinoma ConferencesSkin Cancer ConferenceCancer Conferences

Leukemia Conference, October 17-18, 2016, Italy; 12th World Cancer Conference, September 26-28, 2016 London, UK;  Surgical Oncology Conference, October 03-05, 2016 Atlanta, Georgia, USA 13th Asia-Pacific Oncologists Annual Meeting, October 17-19, 2016, Malaysia, 14th World Cancer Convention, November 21-23, 2016 Dubai, UAE, Bone Marrow Transplantation Conference, October 17-18, 2016,Italy; 25th EADV Congress 28 September - 2 October 2016 - Vienna, Austria; Focus on Melanoma Meeting, RCP, 21 October 2016; 13th International Congress of the Society for Melanoma Research, November 6–9 2016, Boston, Massachusetts; Innovation and Biomarkers in Cancer Drug Development (IBCD) 8-9 September, Brussels, Belgium; Gynecological Cancer Group fall meeting 23-24 September, Lausanne, Switzerland; Gastrointestinal Tract Cancer Group autumn meeting20-22 October, Warsaw, Poland; Melanoma Group meeting, 27-28 October, Lisbon, Portugal; EORTC Symposium on Multidisciplinary Quality Assurance at World Cancer Congress 2016 01 November, Paris, France;

Track 12: Melanoma and Carcinoma Case reports

A case for Amelanotic vulvar melanoma is presented here. The patient was 71-year-old woman complaining of vulvar itching and yellowish vaginal discharge whose it underwent a complete gynaecological evaluation during which a suspicious grey-whitish mass on her vulva was observed. The tumor which is present is a superficial ulceration and it was located in the upper half of the labia minor and the clitoris. Initially it was suspected to be as a vulvar carcinoma.  So the melanoma has the potential to metastasize any organ in the body. The patients with metastatic melanoma usually have a survival of 6-9 months. We report a complete remission in an 80-year-old patient with malignant melanoma. The patient presented with the pulmonary metastases and the history of a multiple resections for local recurrence and the in-transit metastasis. The sweat gland carcinoma is a rare tumor, representing an approximately 1% of the primary skin lesions. In an around 220 cases of sweat gland carcinoma cases has been presented over the last three decades. Then the medium age for that is 57 years, with an equal male-to-female distribution.

Related Melanoma ConferenceCarcinoma ConferencesSkin Cancer ConferenceCancer Conferences

10th Global Annual Oncologists Meeting, July 11-13, 2016 Cologne, Germany; Melanoma Conference, July 14-15, 2016 Brisbane, Australia; Cervical Cancer Conference, August 04-05, 2016 Manchester, UK; Oral Cancer Conference, August 15-17, 2016 Portland, Oregon, USA; 2nd Prostate Cancer Conference, August 22-23, 2016 Philadelphia, USA, Throat Cancer Conference August 15-17, 2016 Portland, Oregon, USA, Carcinoma Conference, July 14-15, 2016 Brisbane, Australia, Mouth Cancer Conference August 15-17, 2016 Portland, Oregon, USA, 16th World Congress on Cancers of the Skin 31st Aug 03 Sep 2016 Vienna, Austria; Clinical Trials – In vitro Diagnostics – Data Protection 07th September Brussels, Belgium; Innovation and Biomarkers in Cancer Drug Development (IBCD) 8-9 September, Brussels, Belgium; Gynecological Cancer Group fall meeting 23-24 September, Lausanne, Switzerland; Gastrointestinal Tract Cancer Group autumn meeting 20-22 October, Warsaw, Poland; Melanoma Group meeting, 27-28 October, Lisbon, Portugal; EORTC Symposium on Multidisciplinary Quality Assurance at World Cancer Congress 2016 01 November, Paris, France; Radiation Oncology Group meeting, 07-08 November, Berlin, Germany;

Track 13: Entrepreneurs Investment Meet

A key ingredient in successful entrepreneurship is self-knowledge. Melanoma 2016 aims to bring together all existing and budding bio entrepreneurs to share experiences and present new innovations and challenges in Skin cancer community. Each year, over a million companies are started in the world with about 5–10 of them classified as high technology companies. Turning ideas into business ventures is tricky and the opportunity-recognition step is critical in new venture creation. This gestalt in the entrepreneur's perception of the relationship between the invention and final product is refined into a business model that describes how the venture will make money or provide an appropriate return to the potential investors. Biological science is complex and rapidly changing and requires a specialized knowledge to understand the value of the innovation and its competitive position in the industry. Although life scientists are typically the founders of biotech companies, studies have shown that the most successful high tech startups are founded by a team of two to three individuals with mixed backgrounds, substantial industry experience and a very clear market and product focus at founding. This two day community-wide conference will be a highly interactive forum that will bring experts in areas ranging from dermatologists, radiologists, oncologists and entire medical team to signalling pathways to novel therapeutic approaches to the scientific hub. In addition to our outstanding speakers, we will also showcase short talks and poster presentations from submitted abstracts. The speakers will discuss on the Cause of the Melanoma and Carcinoma cancer its Types, Diagnosis, Treatment and Therapy, Laboratory Diagnostic Tests, Advance research for Melanoma and Carcinoma, Cancer Nanotechnology, Biomarkers of Melanoma and Carcinoma cancer. This session will include risk factors and investment opportunities for melanoma research. It also deals with Prevention, Diagnosis, Therapy and Treatment of the Skin related Cancers and its innovative techniques.

Related Melanoma ConferenceCarcinoma ConferencesSkin Cancer ConferenceCancer Conferences

Carcinoma Conference, July 14-15, 2016 Brisbane, Australia; 2nd  Paediatric Oncology Conference , June 22-23, 2017 Philadelphia, USA; 2nd  Prostate Cancer Conference, August 22-23, 2016 Philadelphia, Pennsylvania, USA; 10th Global Annual Oncologists Meeting, July 11-13, 2016 Cologne, Germany; Melanoma Conference, July 14-15, 2016 Brisbane, Australia;12th World Cancer ConferenceSeptember 26-28, 2016 London, UK , 12th Congress of the European Association of Dermato-Oncology August 31- Sep 3, 2016 Vienna, Austria;  25th EADV Congress 28 September - 2 October 2016 - Vienna, Austria; Focus on Melanoma Meeting, RCP, 21 October 2016; 13th International Congress of the Society for Melanoma Research, November 6–9 2016, Boston, Massachusetts; Radiation Oncology Group meeting, 07-08 November, Berlin, Germany;  4th Life and Cancer Conference 20-21 April 2017, EU Parliament, Brussels, Belgium; 13th International Gastric Cancer Congress 08-11 May 2019,Prague, Czech Republic;  Molecular Targets and Cancer Therapeutics conference 15-19 November 2019,Miami, Florida, USA; 12th International Symposium on Melanoma and Other Cutaneous Malignancies February 20, 2016 Miami Beach;

 

 

Global Summit on Melanoma & Carcinoma

Date: July 14-15, 2016

Venue: Brisbane, Australia

Melanoma 2016 offers to discuss and debate on various aspects of key challenges, risk factors and investment opportunities for melanoma research.  It also discuss with Prevention, Diagnosis, Therapy and Treatment of the related Skin Cancers and its innovative techniques. Melanoma 2016 is a two days program for staggering growth potential and revolutionizes Skin Cancer treatments, Melanoma cancer treatments, Carcinoma diagnosis over the next 10 years.

In 2009, the average age for melanoma of the skin diagnosis was 60.8 years.The threat of developing melanoma of the skin increases with age.At the end of 2007, it was estimated that, there were 136,016 people in Australia who were detected with melanoma of the skin in the previous 26 years, including 45,753 people analysed in the previous 5 years.Relative survival rates for melanoma of the skin are higher for women than for men in Australia. The five-year comparative survival from melanoma of the skin for 2006-2010 was 88.5 per cent for men besides 93.6 per cent for women. In 2011, there were 1,544 deaths from melanoma of the skin (1,071 men and 473 women), accounting for 3.6 per cent of totally cancer deaths in Australia.In 2014, about 14,240 Australians (8,540 men and 5700 women) are expected to be identified with melanoma of the skin.In 2020, an predictable 17,570 Australians are expected to be detected with melanoma of the skin.

OMICS International beside with its subsidiary ConferenceSeries Ltd  which is encompassed of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on various Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe.

 

Why to attend?

With participants around the world focused on learning about Melanoma and Carcinoma treatment; this is your best opportunity to reach the major assemblage of participants from the Melanoma community, oncology society, and American oncology society. Conduct presentations, distribute the information, meet with recent and potential Cancer scientists, make a splash with new drug developments, and obtain name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the latest updates in Melanoma and Carcinoma are hallmarks of this Global Skin cancer conference.

 

Target Audience

Ø  Oncologists

Ø  Dermatologists

Ø  Radiologists

Ø  Pathologists

Ø  Hematologists

Ø  Academicians

Ø  Research Scholars

Ø  Students

Ø  Hematology Associations & Societies

Ø  Business Entrepreneurs

Ø  Software Developing Companies

Ø  Medical Devices Companies

Ø  Biomedical Companies

Ø  Biotechnology Companies

Ø  Data Management Companies

 

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date July 14-15, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View

Media Partners